Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × danvatirsen × Head & Neck × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2 Thoracic 1 Head & Neck 1 Gynecologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1

Interventions

Cisplatin 102 Cetuximab 83 pembrolizumab 66 Radiotherapy 54 Carboplatin 46 Radiotherapy, Intensity-Modulated 42 Docetaxel 38 Nivolumab 36 Fluorouracil 35 Paclitaxel 34 Radiation 15 durvalumab 14 Erlotinib Hydrochloride 13 lenvatinib 12 Ipilimumab 12 Gemcitabine 12 Bevacizumab 12 Albumin-Bound Paclitaxel 11 vandetanib 10 Platinum 10 Everolimus 10 Drug Therapy 10 epacadostat 9 Pemetrexed 9 Radiosurgery 8 Panitumumab 8 Cyclophosphamide 8 130-nm albumin-bound paclitaxel 8 tremelimumab 7 Surgical Procedures, Operative 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05814666 2026-01-30

PEMDA-HN

Flamingo Therapeutics NV

Phase 2 Terminated

69 enrolled 21 charts

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon ⚡